 Edward Dempsey
Concepts (333)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neprilysin | 6 | 2017 | 47 | 2.310 |
Why?
| | Muscle, Smooth, Vascular | 22 | 2017 | 445 | 2.200 |
Why?
| | Protein Kinase C | 15 | 2007 | 261 | 1.750 |
Why?
| | Pulmonary Artery | 26 | 2020 | 1086 | 1.710 |
Why?
| | Hypoxia | 18 | 2021 | 1112 | 1.200 |
Why?
| | rho GTP-Binding Proteins | 2 | 2020 | 60 | 1.170 |
Why?
| | Pulmonary Circulation | 7 | 2009 | 429 | 0.930 |
Why?
| | Isoenzymes | 9 | 2007 | 304 | 0.700 |
Why?
| | Hypertension, Pulmonary | 12 | 2021 | 1905 | 0.660 |
Why?
| | Lung | 11 | 2021 | 4052 | 0.630 |
Why?
| | Evans Blue | 1 | 2018 | 7 | 0.600 |
Why?
| | Capillary Permeability | 1 | 2018 | 145 | 0.570 |
Why?
| | Cell Division | 25 | 2009 | 792 | 0.550 |
Why?
| | Protein Kinase C-epsilon | 3 | 2005 | 25 | 0.540 |
Why?
| | Myocytes, Smooth Muscle | 2 | 2019 | 261 | 0.520 |
Why?
| | Muscle Proteins | 1 | 2017 | 228 | 0.500 |
Why?
| | Blood Vessels | 3 | 2016 | 187 | 0.480 |
Why?
| | Endothelium, Vascular | 2 | 2020 | 926 | 0.420 |
Why?
| | Receptor, Platelet-Derived Growth Factor beta | 1 | 2013 | 29 | 0.400 |
Why?
| | Aging | 4 | 2020 | 1861 | 0.400 |
Why?
| | Mice, Knockout | 6 | 2017 | 3003 | 0.380 |
Why?
| | Animals | 44 | 2021 | 36823 | 0.380 |
Why?
| | Animals, Newborn | 10 | 2007 | 844 | 0.360 |
Why?
| | Airway Remodeling | 1 | 2010 | 64 | 0.330 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 3 | 2017 | 1036 | 0.310 |
Why?
| | Cattle | 16 | 2002 | 981 | 0.280 |
Why?
| | Fibroblasts | 7 | 2019 | 993 | 0.260 |
Why?
| | Mice | 14 | 2018 | 17733 | 0.250 |
Why?
| | Endothelin-1 | 2 | 2017 | 182 | 0.230 |
Why?
| | Protein Kinases | 1 | 2007 | 319 | 0.230 |
Why?
| | Signal Transduction | 7 | 2020 | 5075 | 0.220 |
Why?
| | Enzyme Activation | 5 | 2017 | 810 | 0.220 |
Why?
| | Lung Neoplasms | 11 | 2012 | 2489 | 0.210 |
Why?
| | rho-Associated Kinases | 2 | 2019 | 83 | 0.210 |
Why?
| | Cells, Cultured | 12 | 2017 | 4190 | 0.200 |
Why?
| | Lung Diseases | 2 | 2007 | 767 | 0.200 |
Why?
| | Potassium Channels, Voltage-Gated | 1 | 2002 | 50 | 0.200 |
Why?
| | Vascular Remodeling | 2 | 2021 | 190 | 0.190 |
Why?
| | Vascular Endothelial Growth Factor Receptor-2 | 3 | 2012 | 86 | 0.190 |
Why?
| | Insulin-Like Growth Factor I | 3 | 1997 | 316 | 0.190 |
Why?
| | Vasoconstriction | 1 | 2002 | 202 | 0.180 |
Why?
| | Growth Substances | 4 | 1997 | 147 | 0.180 |
Why?
| | Mice, Inbred C57BL | 5 | 2017 | 5735 | 0.180 |
Why?
| | Cell Movement | 3 | 2017 | 965 | 0.180 |
Why?
| | Tetradecanoylphorbol Acetate | 5 | 1997 | 150 | 0.180 |
Why?
| | Butyrates | 1 | 2021 | 61 | 0.170 |
Why?
| | Proto-Oncogene Proteins c-myc | 2 | 2020 | 139 | 0.170 |
Why?
| | Metabolic Diseases | 1 | 2021 | 108 | 0.170 |
Why?
| | Mitogens | 2 | 1997 | 61 | 0.170 |
Why?
| | Forkhead Box Protein O3 | 1 | 2020 | 17 | 0.170 |
Why?
| | Vasa Vasorum | 1 | 2020 | 25 | 0.160 |
Why?
| | Platelet-Derived Growth Factor | 3 | 1997 | 91 | 0.160 |
Why?
| | Phenotype | 5 | 2017 | 3188 | 0.160 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2021 | 220 | 0.160 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2020 | 162 | 0.160 |
Why?
| | rhoA GTP-Binding Protein | 1 | 2019 | 86 | 0.150 |
Why?
| | Cellular Microenvironment | 1 | 2019 | 84 | 0.150 |
Why?
| | Genotype | 2 | 2017 | 1914 | 0.150 |
Why?
| | Pulmonary Alveoli | 2 | 2012 | 405 | 0.150 |
Why?
| | Metabolome | 1 | 2021 | 350 | 0.150 |
Why?
| | Thymidine | 5 | 1996 | 60 | 0.140 |
Why?
| | ets-Domain Protein Elk-1 | 1 | 2017 | 12 | 0.140 |
Why?
| | Smooth Muscle Myosins | 1 | 2017 | 6 | 0.140 |
Why?
| | Kruppel-Like Transcription Factors | 1 | 2017 | 66 | 0.140 |
Why?
| | Actins | 3 | 2017 | 416 | 0.130 |
Why?
| | Microfilament Proteins | 1 | 2017 | 131 | 0.130 |
Why?
| | Vascular Diseases | 1 | 2019 | 243 | 0.130 |
Why?
| | Substance P | 1 | 2016 | 36 | 0.130 |
Why?
| | Calcium-Binding Proteins | 1 | 2017 | 218 | 0.130 |
Why?
| | Doxycycline | 1 | 2016 | 62 | 0.130 |
Why?
| | Duodenum | 1 | 2016 | 77 | 0.120 |
Why?
| | Chronic Disease | 6 | 2009 | 1784 | 0.120 |
Why?
| | Neovascularization, Pathologic | 5 | 2020 | 301 | 0.120 |
Why?
| | Pneumonia | 1 | 2021 | 635 | 0.120 |
Why?
| | Sleep Apnea Syndromes | 2 | 2013 | 88 | 0.120 |
Why?
| | Uterus | 3 | 2006 | 215 | 0.110 |
Why?
| | Carcinogens | 2 | 2012 | 124 | 0.110 |
Why?
| | In Vitro Techniques | 5 | 2007 | 1089 | 0.110 |
Why?
| | Myocardium | 1 | 2019 | 1001 | 0.110 |
Why?
| | Cell Communication | 1 | 1996 | 315 | 0.110 |
Why?
| | Sputum | 3 | 2005 | 311 | 0.110 |
Why?
| | Endothelial Cells | 3 | 2021 | 778 | 0.100 |
Why?
| | Humans | 30 | 2021 | 136764 | 0.100 |
Why?
| | Estradiol | 2 | 1997 | 518 | 0.100 |
Why?
| | Enzyme Inhibitors | 4 | 2002 | 839 | 0.100 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 1997 | 858 | 0.100 |
Why?
| | Blotting, Western | 3 | 2012 | 1225 | 0.100 |
Why?
| | Quinazolines | 2 | 2012 | 250 | 0.100 |
Why?
| | Cell Proliferation | 2 | 2017 | 2472 | 0.100 |
Why?
| | Piperidines | 2 | 2012 | 206 | 0.100 |
Why?
| | Gene Expression Regulation | 3 | 2016 | 2605 | 0.090 |
Why?
| | Bronchoscopy | 5 | 2009 | 223 | 0.090 |
Why?
| | Gene Expression Regulation, Enzymologic | 2 | 2005 | 283 | 0.090 |
Why?
| | Mice, Transgenic | 1 | 2016 | 2160 | 0.090 |
Why?
| | DNA Primers | 2 | 2009 | 514 | 0.090 |
Why?
| | Somatomedins | 1 | 1990 | 27 | 0.080 |
Why?
| | Carcinoma in Situ | 3 | 2005 | 49 | 0.080 |
Why?
| | Arteries | 2 | 2006 | 269 | 0.080 |
Why?
| | Precancerous Conditions | 3 | 2004 | 169 | 0.080 |
Why?
| | Maleimides | 3 | 2000 | 23 | 0.080 |
Why?
| | Isotretinoin | 1 | 2009 | 26 | 0.080 |
Why?
| | Tocopherols | 1 | 2009 | 26 | 0.080 |
Why?
| | Cardiovascular Diseases | 1 | 2021 | 2104 | 0.080 |
Why?
| | Cell Hypoxia | 3 | 1999 | 226 | 0.080 |
Why?
| | ErbB Receptors | 1 | 2012 | 613 | 0.080 |
Why?
| | Blood Pressure | 3 | 2021 | 1774 | 0.070 |
Why?
| | Biomarkers | 1 | 2020 | 4143 | 0.070 |
Why?
| | Biomarkers, Tumor | 3 | 2012 | 1272 | 0.070 |
Why?
| | Carcinoma, Squamous Cell | 2 | 2005 | 683 | 0.070 |
Why?
| | Female | 17 | 2012 | 72787 | 0.070 |
Why?
| | Galectin 1 | 1 | 2006 | 2 | 0.070 |
Why?
| | Bronchi | 2 | 2000 | 260 | 0.070 |
Why?
| | Genes, ras | 2 | 1997 | 97 | 0.060 |
Why?
| | Hyperoxia | 1 | 2007 | 90 | 0.060 |
Why?
| | Indoles | 3 | 2000 | 410 | 0.060 |
Why?
| | Videotape Recording | 1 | 2006 | 35 | 0.060 |
Why?
| | Male | 10 | 2018 | 67309 | 0.060 |
Why?
| | Heart Failure | 1 | 2019 | 2231 | 0.060 |
Why?
| | Thiazolidinediones | 1 | 2006 | 137 | 0.060 |
Why?
| | Hypertrophy, Right Ventricular | 2 | 2021 | 145 | 0.060 |
Why?
| | Rats, Sprague-Dawley | 3 | 2021 | 2486 | 0.060 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2005 | 173 | 0.060 |
Why?
| | Smoking | 4 | 2009 | 1620 | 0.060 |
Why?
| | DNA | 4 | 1997 | 1458 | 0.060 |
Why?
| | Blood | 2 | 1995 | 107 | 0.060 |
Why?
| | Disease Models, Animal | 2 | 2013 | 4281 | 0.060 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2005 | 204 | 0.060 |
Why?
| | Rats | 4 | 2021 | 5639 | 0.060 |
Why?
| | Endothelins | 2 | 1996 | 65 | 0.060 |
Why?
| | Calcium | 2 | 2002 | 1197 | 0.050 |
Why?
| | Drug Synergism | 3 | 1996 | 382 | 0.050 |
Why?
| | Guinea Pigs | 3 | 2006 | 158 | 0.050 |
Why?
| | Hemodynamics | 1 | 2009 | 1110 | 0.050 |
Why?
| | Bronchoalveolar Lavage Fluid | 2 | 1997 | 652 | 0.050 |
Why?
| | Drug Delivery Systems | 1 | 2007 | 362 | 0.050 |
Why?
| | Shaw Potassium Channels | 1 | 2002 | 4 | 0.050 |
Why?
| | Potassium Chloride | 1 | 2002 | 38 | 0.050 |
Why?
| | Potassium Channel Blockers | 1 | 2002 | 37 | 0.050 |
Why?
| | Stem Cells | 1 | 2007 | 592 | 0.050 |
Why?
| | Fetus | 2 | 1997 | 806 | 0.050 |
Why?
| | Case-Control Studies | 1 | 2010 | 3540 | 0.050 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2005 | 455 | 0.050 |
Why?
| | Angiotensin II | 1 | 2002 | 99 | 0.050 |
Why?
| | Nitric Oxide Synthase | 1 | 2002 | 240 | 0.050 |
Why?
| | Potassium Channels | 1 | 2002 | 151 | 0.050 |
Why?
| | Tunica Media | 2 | 1998 | 38 | 0.050 |
Why?
| | Urethane | 2 | 2012 | 43 | 0.050 |
Why?
| | Protein Kinase C beta | 2 | 2000 | 21 | 0.050 |
Why?
| | Antineoplastic Agents | 2 | 2010 | 2122 | 0.040 |
Why?
| | Systole | 1 | 2021 | 189 | 0.040 |
Why?
| | Gene Deletion | 1 | 2002 | 389 | 0.040 |
Why?
| | Fluorescence | 1 | 2001 | 160 | 0.040 |
Why?
| | Tight Junctions | 1 | 2021 | 76 | 0.040 |
Why?
| | Patient Education as Topic | 1 | 2006 | 761 | 0.040 |
Why?
| | Acetylation | 1 | 2021 | 248 | 0.040 |
Why?
| | Microvessels | 1 | 2021 | 85 | 0.040 |
Why?
| | Receptors, Purinergic P2Y | 1 | 2020 | 7 | 0.040 |
Why?
| | Macrophages | 2 | 2021 | 1544 | 0.040 |
Why?
| | Genetic Predisposition to Disease | 1 | 2009 | 2412 | 0.040 |
Why?
| | Nitric Oxide | 1 | 2005 | 915 | 0.040 |
Why?
| | Ligands | 1 | 2021 | 661 | 0.040 |
Why?
| | Aged | 6 | 2010 | 23794 | 0.040 |
Why?
| | Cytokines | 2 | 2021 | 2083 | 0.040 |
Why?
| | GTPase-Activating Proteins | 1 | 2019 | 82 | 0.040 |
Why?
| | Guanine Nucleotide Exchange Factors | 1 | 2019 | 66 | 0.040 |
Why?
| | Trans-Activators | 1 | 2001 | 398 | 0.040 |
Why?
| | Light | 1 | 2001 | 378 | 0.040 |
Why?
| | Up-Regulation | 1 | 2021 | 843 | 0.040 |
Why?
| | Immune System | 1 | 2019 | 177 | 0.040 |
Why?
| | Leukocytes | 1 | 2019 | 311 | 0.040 |
Why?
| | Oxygen | 1 | 2002 | 930 | 0.040 |
Why?
| | Neoplasms | 1 | 2013 | 2644 | 0.040 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2020 | 366 | 0.040 |
Why?
| | Aorta | 2 | 2001 | 417 | 0.030 |
Why?
| | Culture Media, Serum-Free | 1 | 1997 | 48 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-sis | 1 | 1997 | 37 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2020 | 437 | 0.030 |
Why?
| | Disease Susceptibility | 1 | 2019 | 345 | 0.030 |
Why?
| | Adenosine Triphosphate | 1 | 2020 | 487 | 0.030 |
Why?
| | Protein Kinase C-alpha | 1 | 1997 | 37 | 0.030 |
Why?
| | Ischemia | 1 | 2000 | 407 | 0.030 |
Why?
| | Organ Specificity | 1 | 1997 | 304 | 0.030 |
Why?
| | Pregnancy, Animal | 1 | 1997 | 52 | 0.030 |
Why?
| | Bronchial Neoplasms | 1 | 1996 | 15 | 0.030 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2020 | 412 | 0.030 |
Why?
| | Muscle Development | 1 | 1997 | 111 | 0.030 |
Why?
| | Microcirculation | 2 | 2007 | 146 | 0.030 |
Why?
| | Sensitivity and Specificity | 2 | 2001 | 1935 | 0.030 |
Why?
| | Nuclear Proteins | 1 | 2001 | 712 | 0.030 |
Why?
| | Species Specificity | 1 | 1997 | 584 | 0.030 |
Why?
| | Heart Ventricles | 1 | 2021 | 785 | 0.030 |
Why?
| | Rabbits | 1 | 1997 | 792 | 0.030 |
Why?
| | Reactive Oxygen Species | 1 | 2019 | 621 | 0.030 |
Why?
| | Blood Physiological Phenomena | 1 | 1996 | 13 | 0.030 |
Why?
| | Receptors, Platelet-Derived Growth Factor | 1 | 1996 | 15 | 0.030 |
Why?
| | Tritium | 1 | 1996 | 76 | 0.030 |
Why?
| | Point Mutation | 1 | 1997 | 235 | 0.030 |
Why?
| | Middle Aged | 5 | 2010 | 33228 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2010 | 2052 | 0.030 |
Why?
| | Rats, Inbred Strains | 1 | 1996 | 362 | 0.030 |
Why?
| | Neoplasms, Second Primary | 1 | 1997 | 116 | 0.030 |
Why?
| | DNA Mutational Analysis | 1 | 1996 | 399 | 0.030 |
Why?
| | Protein Precursors | 1 | 1996 | 132 | 0.030 |
Why?
| | Myocytes, Cardiac | 1 | 2019 | 523 | 0.030 |
Why?
| | Catalysis | 1 | 1995 | 307 | 0.030 |
Why?
| | Subcellular Fractions | 1 | 1994 | 82 | 0.030 |
Why?
| | Adenosine Diphosphate | 1 | 1994 | 79 | 0.030 |
Why?
| | Clinical Trials as Topic | 1 | 2019 | 1044 | 0.030 |
Why?
| | Exercise | 1 | 2006 | 2043 | 0.030 |
Why?
| | Models, Biological | 1 | 2021 | 1773 | 0.030 |
Why?
| | Flow Cytometry | 2 | 1996 | 1177 | 0.030 |
Why?
| | Quality of Life | 1 | 2006 | 2878 | 0.030 |
Why?
| | Stress, Mechanical | 1 | 1996 | 481 | 0.030 |
Why?
| | Recombinant Proteins | 1 | 1997 | 1350 | 0.030 |
Why?
| | Poly I-C | 1 | 1994 | 63 | 0.030 |
Why?
| | Blood Proteins | 1 | 1996 | 252 | 0.030 |
Why?
| | Young Adult | 1 | 2010 | 13129 | 0.030 |
Why?
| | Endothelin Receptor Antagonists | 1 | 1993 | 62 | 0.030 |
Why?
| | Hyperplasia | 2 | 2006 | 175 | 0.030 |
Why?
| | Complement Factor B | 1 | 1994 | 109 | 0.030 |
Why?
| | Neoplasm Proteins | 1 | 1996 | 434 | 0.030 |
Why?
| | Receptors, Estrogen | 1 | 1996 | 436 | 0.020 |
Why?
| | Risk Factors | 5 | 2009 | 10326 | 0.020 |
Why?
| | Methylcholanthrene | 1 | 2012 | 22 | 0.020 |
Why?
| | Butylated Hydroxytoluene | 1 | 2012 | 38 | 0.020 |
Why?
| | Extracellular Matrix | 2 | 2006 | 528 | 0.020 |
Why?
| | Serotonin | 1 | 1994 | 323 | 0.020 |
Why?
| | Immunoenzyme Techniques | 1 | 2012 | 219 | 0.020 |
Why?
| | Peptides, Cyclic | 1 | 1993 | 259 | 0.020 |
Why?
| | Time Factors | 2 | 2007 | 6806 | 0.020 |
Why?
| | Apoptosis | 1 | 2000 | 2551 | 0.020 |
Why?
| | Phorbol 12,13-Dibutyrate | 1 | 1991 | 8 | 0.020 |
Why?
| | Cell Count | 2 | 2006 | 323 | 0.020 |
Why?
| | Aerobiosis | 1 | 1991 | 21 | 0.020 |
Why?
| | Pregnancy | 3 | 2006 | 6728 | 0.020 |
Why?
| | Adolescent | 1 | 2010 | 21382 | 0.020 |
Why?
| | Dimethyl Sulfoxide | 1 | 1991 | 41 | 0.020 |
Why?
| | Anaerobiosis | 1 | 1991 | 64 | 0.020 |
Why?
| | Blood Platelets | 1 | 1994 | 405 | 0.020 |
Why?
| | Infant, Newborn | 2 | 2007 | 6033 | 0.020 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2012 | 209 | 0.020 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2012 | 242 | 0.020 |
Why?
| | Tumor Cells, Cultured | 3 | 1996 | 953 | 0.020 |
Why?
| | Chemoprevention | 1 | 2010 | 92 | 0.020 |
Why?
| | Biopsy | 2 | 2005 | 1124 | 0.020 |
Why?
| | Protein Binding | 1 | 1996 | 2216 | 0.020 |
Why?
| | DNA Replication | 1 | 1991 | 238 | 0.020 |
Why?
| | Antioxidants | 1 | 2012 | 584 | 0.020 |
Why?
| | RNA, Messenger | 1 | 1996 | 2831 | 0.020 |
Why?
| | Down-Regulation | 1 | 1990 | 656 | 0.020 |
Why?
| | Leukocyte Common Antigens | 1 | 2007 | 87 | 0.020 |
Why?
| | Kinetics | 1 | 1991 | 1663 | 0.020 |
Why?
| | Molecular Targeted Therapy | 1 | 2010 | 411 | 0.020 |
Why?
| | Rats, Inbred WKY | 1 | 2006 | 36 | 0.020 |
Why?
| | Elastin | 1 | 2006 | 78 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-kit | 1 | 2006 | 67 | 0.020 |
Why?
| | Codon | 2 | 1997 | 89 | 0.020 |
Why?
| | PPAR gamma | 1 | 2006 | 182 | 0.020 |
Why?
| | Serum | 1 | 2006 | 59 | 0.020 |
Why?
| | Aged, 80 and over | 2 | 2009 | 7585 | 0.010 |
Why?
| | Vascular Resistance | 1 | 2006 | 372 | 0.010 |
Why?
| | Chi-Square Distribution | 1 | 2006 | 530 | 0.010 |
Why?
| | Collagen | 1 | 2006 | 446 | 0.010 |
Why?
| | Protein Kinase Inhibitors | 1 | 2010 | 916 | 0.010 |
Why?
| | Sheep | 1 | 2006 | 856 | 0.010 |
Why?
| | Teaching | 1 | 2006 | 224 | 0.010 |
Why?
| | Polymerase Chain Reaction | 2 | 1997 | 1059 | 0.010 |
Why?
| | Confidence Intervals | 1 | 2004 | 328 | 0.010 |
Why?
| | Neoplasm Invasiveness | 1 | 2005 | 507 | 0.010 |
Why?
| | Antibodies, Monoclonal | 1 | 2010 | 1430 | 0.010 |
Why?
| | Adenocarcinoma | 1 | 2010 | 938 | 0.010 |
Why?
| | Vital Capacity | 1 | 2004 | 311 | 0.010 |
Why?
| | Epithelial Cells | 2 | 2001 | 1094 | 0.010 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2009 | 1058 | 0.010 |
Why?
| | Base Sequence | 1 | 2006 | 2179 | 0.010 |
Why?
| | Forced Expiratory Volume | 1 | 2004 | 531 | 0.010 |
Why?
| | Gestational Age | 1 | 2006 | 902 | 0.010 |
Why?
| | Activities of Daily Living | 1 | 2006 | 413 | 0.010 |
Why?
| | Bronchopulmonary Dysplasia | 1 | 2007 | 382 | 0.010 |
Why?
| | Patient Compliance | 1 | 2006 | 577 | 0.010 |
Why?
| | CREB-Binding Protein | 1 | 2001 | 31 | 0.010 |
Why?
| | Metaplasia | 1 | 2001 | 60 | 0.010 |
Why?
| | Single-Blind Method | 1 | 2001 | 282 | 0.010 |
Why?
| | Adaptation, Psychological | 1 | 2006 | 651 | 0.010 |
Why?
| | Fluorescent Antibody Technique | 1 | 2001 | 388 | 0.010 |
Why?
| | Chromosomes, Human, Pair 3 | 1 | 2000 | 50 | 0.010 |
Why?
| | Loss of Heterozygosity | 1 | 2000 | 51 | 0.010 |
Why?
| | Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2000 | 52 | 0.010 |
Why?
| | Ki-67 Antigen | 1 | 2000 | 111 | 0.010 |
Why?
| | Airway Obstruction | 1 | 2001 | 162 | 0.010 |
Why?
| | Carcinoma | 1 | 2001 | 238 | 0.010 |
Why?
| | Fibrosis | 1 | 2002 | 551 | 0.010 |
Why?
| | Risk | 1 | 2001 | 908 | 0.010 |
Why?
| | Cell Death | 1 | 2000 | 372 | 0.010 |
Why?
| | Prevalence | 1 | 2005 | 2711 | 0.010 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 2 | 1997 | 1076 | 0.010 |
Why?
| | Mitotic Index | 1 | 1997 | 25 | 0.010 |
Why?
| | Bromodeoxyuridine | 1 | 1997 | 79 | 0.010 |
Why?
| | Cytoskeletal Proteins | 1 | 1997 | 156 | 0.010 |
Why?
| | Tunica Intima | 1 | 1997 | 84 | 0.010 |
Why?
| | Mammals | 1 | 1999 | 283 | 0.010 |
Why?
| | Chromosome Banding | 1 | 1996 | 19 | 0.010 |
Why?
| | Myosins | 1 | 1997 | 132 | 0.010 |
Why?
| | Ploidies | 1 | 1996 | 18 | 0.010 |
Why?
| | Karyotyping | 1 | 1996 | 104 | 0.010 |
Why?
| | Ligases | 1 | 1996 | 32 | 0.010 |
Why?
| | Comorbidity | 1 | 2001 | 1614 | 0.010 |
Why?
| | Ovariectomy | 1 | 1997 | 152 | 0.010 |
Why?
| | Bronchoalveolar Lavage | 1 | 1996 | 93 | 0.010 |
Why?
| | Heparin | 1 | 1997 | 260 | 0.010 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2000 | 528 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2000 | 1733 | 0.010 |
Why?
| | Immunophenotyping | 1 | 1996 | 318 | 0.010 |
Why?
| | Regional Blood Flow | 1 | 1997 | 473 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 2001 | 1455 | 0.010 |
Why?
| | HeLa Cells | 1 | 1996 | 633 | 0.010 |
Why?
| | Calcimycin | 1 | 1994 | 49 | 0.010 |
Why?
| | Epidermal Growth Factor | 1 | 1994 | 175 | 0.010 |
Why?
| | Mice, Inbred C3H | 1 | 1994 | 269 | 0.010 |
Why?
| | Interferon-beta | 1 | 1994 | 92 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2006 | 5742 | 0.010 |
Why?
| | Cell Survival | 1 | 1996 | 1114 | 0.010 |
Why?
| | Mass Screening | 1 | 2001 | 1267 | 0.010 |
Why?
| | Neoplasm Staging | 1 | 1997 | 1371 | 0.010 |
Why?
| | Prognosis | 1 | 2001 | 4013 | 0.010 |
Why?
| | Adult | 2 | 2009 | 37630 | 0.010 |
Why?
| | Macrophage Activation | 1 | 1994 | 201 | 0.010 |
Why?
| | Analysis of Variance | 1 | 1993 | 1316 | 0.010 |
Why?
| | Interferon-gamma | 1 | 1994 | 788 | 0.010 |
Why?
| | Mutation | 1 | 2000 | 3946 | 0.000 |
Why?
| | Peptides | 1 | 1994 | 979 | 0.000 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 1994 | 1242 | 0.000 |
Why?
| | Retrospective Studies | 1 | 2005 | 15504 | 0.000 |
Why?
|
|
Dempsey's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|